Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Patients treated with novel regenerative therapy developed by Dr. Duncan Stewart
June 19, 2008
The Jewish General Hospital announced today that it has treated two pulmonary hypertension patients with a novel regenerative therapy developed by Dr. Duncan Stewart, CEO and Scientific Director of the Ottawa Hospital Research Institute (OHRI), Vice President of Research at The Ottawa Hospital, Professor of Medicine at the University of Ottawa and Founding Scientist of Northern Therapeutics.
The patients are the third and fourth to be treated as part of a clinical trial that was initiated during Dr. Stewart’s previous position at St. Michael’s Hospital in Toronto. The trial is unique in the world, as it is the first to employ patient stem cells genetically modified for clinical use in lung disease.
There is reason to believe that a similar “enhanced” cell therapy may able to help heal the heart after a heart attack and Dr. Stewart expects to test this soon in another clinical trial that would take place in several Canadian cities, including Ottawa.
Links
Press release from the Jewish General Hospital
Dr. Duncan Stewart’s OHRI Scientist Profile
CTV story on the first pulmonary hypertension patient treated in this trial